Insights into the role of the von Hippel-Lindau gene product: A key player in hypoxic regulation

Experimental Nephrology

Volumn 9, Issue 4, 2001, Pages 235-240

  Maxwell, P H ^a,b   Pugh, C W ^a   Ratcliffe, P J ^a  

^a Henry Wellcome Building of Genomic Medicine   (United Kingdom)

^b Henry Wellcome Building of Genomic Medicine ^*  (United Kingdom)

Author keywords

Hypoxia; Hypoxia inducible factor 1; Oxygen; Von Hippel Lindau

Indexed keywords

GENE PRODUCT; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN;

ADAPTATION; CARCINOGENESIS; CLEAR CELL CARCINOMA; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; HYPOXIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT SURVEY; VON HIPPEL LINDAU DISEASE;

ANOXIA; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HELIX-LOOP-HELIX MOTIFS; HIPPEL-LINDAU DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0034936702     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (25)

1. HIF-1 and human disease: One highly involved factor
2. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: Evidence for a widespread oxygen sensing mechanism
3. 2 tension
4. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
5. The VHL tumour-suppressor gene paradigm
6. Identification of the von Hippel-Lindau disease tumor suppressor gene
7. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins
8. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2
9. Structure of the VHL-elonginC-elonginB complex: Implications for VHL tumor suppressor function
10. Combinatorial control in ubiquitin-dependent proteolysis: Don't Skp the F-box hypothesis
11. The ubiquitin system
12. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
13. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
14. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
15. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
16. Hypoxia inducible expression of tumor associated carbonic anhydrases
17. Identification of novel hypoxia-dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling
18. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
19. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
20. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages
21. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
22. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
23. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
24. 2 sensing
25. 2-regulated prolyl hydroxylation